Journal ArticleDOI
Cardiovascular Comorbidity in COPD: Systematic Literature Review
TLDR
Available observational data support the hypothesis that COPD is associated with an increased risk of CVD, and two studies found a relationship between the severity of airflow limitation and CVD risk.About:
This article is published in Chest.The article was published on 2013-10-01. It has received 251 citations till now. The article focuses on the topics: Rate ratio & COPD.read more
Citations
More filters
Journal ArticleDOI
Exacerbations of Chronic Obstructive Pulmonary Disease and Cardiac Events. A Post Hoc Cohort Analysis from the SUMMIT Randomized Clinical Trial.
Ken M. Kunisaki,Ken M. Kunisaki,Mark T. Dransfield,Mark T. Dransfield,Julie A. Anderson,Robert D. Brook,Peter M.A. Calverley,Bartolome R. Celli,Courtney Crim,Benjamin Hartley,Fernando J. Martinez,David E. Newby,Alexa A. Pragman,Alexa A. Pragman,Jørgen Vestbo,Julie C. Yates,Dennis E. Niewoehner,Dennis E. Niewoehner +17 more
TL;DR: In patients with COPD with CVD or risk factors for CVD, exacerbations confer an increased risk of subsequent CVD events, especially in hospitalized patients and within the first 30 days after exacerbation.
Journal ArticleDOI
The path to personalised medicine in COPD
TL;DR: A brief perspective of the extraordinary transition that the COPD field has experienced in the last two decades is provided, and how it should/can move forward in the near future in order to really achieve the goal of personalising COPD medicine in the clinic is speculated.
Journal ArticleDOI
Chronic Obstructive Pulmonary Disease and Cardiac Diseases. An Urgent Need for Integrated Care.
TL;DR: The aim of this review is to summarize the evidence of the relationship between COPD and the three most frequent and important cardiac comorbidities in patients with COPD: ischemic heart disease, heart failure, and atrial fibrillation.
Journal ArticleDOI
Comorbidities and Chronic Obstructive Pulmonary Disease: Prevalence, Influence on Outcomes, and Management.
TL;DR: Existing knowledge about comorbidity burden and specific comorebidities in COPD are summarized, focusing on prevalence estimates, association with outcomes, and existing knowledge about treatment strategies.
Journal ArticleDOI
Nighttime Blood Pressure Phenotype and Cardiovascular Prognosis: Practitioner-Based Nationwide JAMP Study.
Kazuomi Kario,Satoshi Hoshide,Hiroyuki Mizuno,Tomoyuki Kabutoya,Masafumi Nishizawa,Tetsuro Yoshida,Hideyasu Abe,Tomohiro Katsuya,Yumiko Fujita,Osamu Okazaki,Yuichiro Yano,Naoko Tomitani,Hiroshi Kanegae +12 more
TL;DR: This research presents a novel probabilistic approach that allows us to assess the importance of knowing the carrier and removal status of canine coronavirus, as a source of infection for other animals.
References
More filters
Journal ArticleDOI
Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary.
Jørgen Vestbo,Suzanne S. Hurd,Alvar Agusti,Paul W. Jones,Claus Vogelmeier,Antonio Anzueto,Peter J. Barnes,Leonardo M. Fabbri,Fernando J. Martinez,Masaharu Nishimura,Robert A. Stockley,Don D. Sin,Roberto Rodriguez-Roisin +12 more
TL;DR: It is recommended that spirometry is required for the clinical diagnosis of COPD to avoid misdiagnosis and to ensure proper evaluation of severity of airflow limitation.
Journal ArticleDOI
Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis
TL;DR: Reduced lung function is associated with increased levels of systemic inflammatory markers which may have important pathophysiological and therapeutic implications for subjects with stable COPD.
Journal ArticleDOI
Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD.
TL;DR: Subjects with GOLD stage 3 or 4 COPD had a higher prevalence of diabetes, which contributes to a higher risk of adverse outcomes of mortality and hospitalisations, and subjects with impaired lung function had more comorbid disease.
Journal ArticleDOI
Mortality in COPD: Role of comorbidities.
TL;DR: The current paper reviews the role of comorbidities in chronic obstructive pulmonary disease mortality, the putative underlying pathogenic link between chronic obstructives pulmonary disease and comorbrid conditions (i.e. inflammation), and the tools used to predict Chronic obstructivemonary disease mortality.
Journal ArticleDOI
Systemic effects of chronic obstructive pulmonary disease
TL;DR: In this article, the authors discuss the following systemic effects of chronic obstructive pulmonary disease: 1) systemic inflammation; 2) nutritional abnormalities and weight loss; 3) skeletal muscle dysfunction; 4) other potential systemic effects.